The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms, islet structure and function, morphology, in vitro and in vivo models, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2025 will take place on Thursday, 1st & Friday, 2nd May 2025 at the University of Adelaide in Adelaide, SA.

Click here to view the event flyer.
Click here for abstract submission details.
Click here to register for the event.

Full registration: A$190.00 (GST included)
Student registration: A$90.00 (GST included)

Call for Abstracts

The abstract submission deadline is 17 April 2025.

Abstracts should be emailed to ads@diabetessociety.com.au. Please format and organise the abstract as specified below, and include all outlined information. Please provide the following:

Author Information
State all authors, with presenting author’s name underlined. Please indicate if the presenting author is a young investigator (PhD student or Postdoctoral fellow less than 5 years post PhD graduation).

State full first and last names and affiliation details for each author.

Abstract Format
• A4 (portrait)
• 500 words maximum
• Abstract title in bold

Abstract Layout
Organise the abstract with the following sections: Background, Objectives, Methods, Results, Conclusions

Presentation Format at the 2025 AISG Meeting
Below the abstract, please indicate your presentation format of choice (poster or talk) and state the name, email address and phone number of the submitting author.

You will receive a confirmation email after submission. The Committee will review all submitted abstracts. Notification regarding abstract acceptance and scheduling will be sent to the submitting author.

Speakers

Keynote Speaker Professor James Johnson James Johnson is a Professor in the Department of Cellular & Physiological Sciences and the Department of Surgery at the University of British Columbia (UBC) in Canada. He is the Director of the Laboratory of Molecular Signalling in Diabetes at the UBC Life Sciences Institute. He is also Editor-in-Chief of the journal Islets. A leader in the fundamental biology of pancreatic islets, insulin action, diabetes and their connections to co-morbidities, Professor Johnson is the author of >145 peer-reviewed articles since starting in 2000. His laboratory at the UBC Life Sciences Institute focuses on understanding the causes of type 1 and type 2 diabetes at a molecular level. Professor Johnson and his team study the role of the insulin-secreting pancreatic beta-cell in type 1 diabetes, type 2 diabetes, and other rare forms of diabetes using state-of-the-art techniques including molecular imaging, molecular biology and in vivo studies.

More details to be advised. Stay tuned!